ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS
Delisted
ARDS was delisted on the 18th of July, 2023.
19 hedge funds and large institutions have $2.04M invested in Aridis Pharmaceuticals Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$12K | |
| 2 | +$9K | |
| 3 | +$7.17K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.37K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.91K |
Top Sellers
| 1 | -$42K | |
| 2 | -$21K | |
| 3 | -$20.4K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$16K |